From the Editor

Should Everyone with Prostate Cancer be on a Statin?

Alicia Morgans
October 26, 2017

I am regularly asked about whether men undergoing active treatment for prostate cancer should add a statin to their daily medication routine to reduce the risk of prostate cancer recurrence, mortality, and complications.  Nearly as often I hear questions about whether statins may be of use in prostate cancer survivors or men at risk of prostate cancer, raising the general idea that everyone and anyone may benefit from treatment with these commonly used medications. 

READ MORE PREVIOUS ARTICLES

Alicia Morgans, MD

Alicia Morgans, MD, MPH

Alicia Morgans, MD, MPH is an Associate Professor of Medicine in the Division of Hematology/Oncology at the Northwestern University Feinberg School of Medicine in Chicago, Illinois. She completed her MD and internal medicine residency at the University Of Pennsylvania Perelman School Of Medicine, and her fellowship at Dana Farber Cancer Institute/MGH Cancer Center. She is a clinician and physician investigator specializing is investigating complications of systemic therapy for prostate cancer survivors. Her work has included the study of skeletal, cardiovascular, diabetic, and cognitive complications of prostate cancer survivorship, as well as treatment decision making in the metastatic prostate cancer population. She has expertise in clinical trials and patient reported outcome measures, and as well as incorporating patient preferences and beliefs into clinical decision making.

Video Lectures
State-of-the-industry video lectures by leading urology experts
@UroToday